-
April 2022
EP, US, JP, CA pending
-
August 2021
Leucotox starts compound modification for increased treatment efficacy in mouse models
-
November 2020
EPO Patent Publication
-
August 2020
LeucoTox performed first xenograft experiments with substantial treatment efficacy.
-
October 2020
Preclinical models show efficacy of LeucoTox in myeloid leukemia in vivo.
-
May 2019
LeucoTox submitted patent application at the European Patent Office.